MFVNX | VITSX | MFVNX / VITSX | |
Total Expense Ratio | 1.46 | 0.03 | 4,867% |
Annual Report Gross Expense Ratio | 1.46 | 0.03 | 4,867% |
Fund Existence | 23 years | 28 years | - |
Gain YTD | 5.105 | 8.295 | 62% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 379M | 1.91T | 0% |
Annual Yield % from dividends | 0.86 | 1.22 | 71% |
Returns for 1 year | -7.52 | 17.76 | -42% |
Returns for 3 years | -9.86 | 60.63 | -16% |
Returns for 5 years | -4.63 | 93.55 | -5% |
Returns for 10 years | -31.51 | 201.65 | -16% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EDD | 5.12 | 0.03 | +0.59% |
Morgan Stanley Emerging Markets Domestic Debt Fund | |||
PSMR | 28.73 | 0.04 | +0.14% |
Pacer Swan SOS Moderate (April) ETF | |||
KSPY | 27.06 | 0.03 | +0.09% |
KraneShares Hedgeye Hedged Eq Idx ETF | |||
FALN | 27.11 | 0.02 | +0.07% |
iShares Fallen Angels USD Bond ETF | |||
HELX | 28.31 | -0.09 | -0.31% |
Franklin Genomic Advancements ETF |